StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
PDS Biotechnology Corporation
NasdaqCM:PDSB
Sector
Industries
Location
Market Cap
USD 57.14 M
Share Price
USD 1.25
Avg Daily Volume
516,926
Change (1 day)
8.70%
Change (1 year)
-70.45%
Change (YTD)
-23.31%
PDS Biotechnology Corporation Common Stock Issued for the Trailing 12 Months (TTM) ending June 30, 2024: USD 30.79 M
PDS Biotechnology Corporation Common Stock Issued is USD 30.79 M for the Trailing 12 Months (TTM) ending June 30, 2024, a 109.60% change year over year. Common stock issued is cash received from issuing new shares of the company’s common stock.
-
PDS Biotechnology Corporation Common Stock Issued for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 14.69 M, a 9,473.02% change year over year.
-
PDS Biotechnology Corporation Common Stock Issued for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 153.44 K.
Competitors
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Moderna, Inc.
USD 34.67
MRNA
+1.94
5.93%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.43
603392.SS
+0.06
0.69%
Swedish Orphan Biovitrum AB (publ)
USD 28.81
SOBI.ST
+0.48
1.70%
Chongqing Zhifei Biological Products Co., Ltd.
USD 3.03
300122.SZ
+0.15
5.21%
Ionis Pharmaceuticals, Inc.
USD 42.38
IONS
+0.43
1.03%
Rhythm Pharmaceuticals, Inc.
USD 87.81
RYTM
-0.01
-0.01%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.21
1877.HK
+0.12
3.93%
Vaxcyte, Inc.
USD 36.46
PCVX
+0.74
2.07%
Hualan Biological Engineering Inc.
USD 2.30
002007.SZ
+0.01
0.61%
NewAmsterdam Pharma Company N.V.
USD 23.98
NAMS
+1.05
4.58%
Ligand Pharmaceuticals Incorporated
USD 136.21
LGND
+3.75
2.83%
Apellis Pharmaceuticals, Inc.
USD 19.90
APLS
+0.01
0.05%
Apogee Therapeutics, Inc.
USD 40.58
APGE
+0.98
2.48%
Bavarian Nordic A/S
USD 30.28
BAVA.CO
+1.17
4.03%
Immunocore Holdings plc
USD 36.05
IMCR
-1.10
-2.96%
ARS Pharmaceuticals, Inc.
USD 18.00
SPRY
+0.41
2.33%
Adaptive Biotechnologies Corporation
USD 10.87
ADPT
+0.34
3.23%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Key Data
| Date | Common Stock Issued | Common Stock Repurchased | Free Cash Flow | Operating Cash Flow |
|---|
Competitors
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Moderna, Inc.
USD 34.67
MRNA
+1.94
5.93%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.43
603392.SS
+0.06
0.69%
Swedish Orphan Biovitrum AB (publ)
USD 28.81
SOBI.ST
+0.48
1.70%
Chongqing Zhifei Biological Products Co., Ltd.
USD 3.03
300122.SZ
+0.15
5.21%
Ionis Pharmaceuticals, Inc.
USD 42.38
IONS
+0.43
1.03%
Rhythm Pharmaceuticals, Inc.
USD 87.81
RYTM
-0.01
-0.01%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.21
1877.HK
+0.12
3.93%
Vaxcyte, Inc.
USD 36.46
PCVX
+0.74
2.07%
Hualan Biological Engineering Inc.
USD 2.30
002007.SZ
+0.01
0.61%
NewAmsterdam Pharma Company N.V.
USD 23.98
NAMS
+1.05
4.58%
Ligand Pharmaceuticals Incorporated
USD 136.21
LGND
+3.75
2.83%
Apellis Pharmaceuticals, Inc.
USD 19.90
APLS
+0.01
0.05%
Apogee Therapeutics, Inc.
USD 40.58
APGE
+0.98
2.48%
Bavarian Nordic A/S
USD 30.28
BAVA.CO
+1.17
4.03%
Immunocore Holdings plc
USD 36.05
IMCR
-1.10
-2.96%
ARS Pharmaceuticals, Inc.
USD 18.00
SPRY
+0.41
2.33%
Adaptive Biotechnologies Corporation
USD 10.87
ADPT
+0.34
3.23%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%